Dear
Readers,
After
about two and half years using Blogger as the primary medium for sharing my
thoughts, notes and links, The Inoculated Investor has found a new home.
Specifically, the change is being made due to some compliance concerns and,
most importantly, my overwhelming desire to have the time I spend blogging
benefit my new firm, Cove Street Capital, as well.
The good news is that
nothing is going to change other than the website. In fact, I may even be
posting more often than I was in the past. In addition to commentary pieces and
notes from the seminal events of the year—the Berkshire annual meeting for
example—I hope to also post notes from industry conferences and management
meetings. Further, readers will also have access to material from portfolio
manager Jeff Bronchick, who used to write for TheStreet.com, and Eugene Robin,
my partner in crime on the analyst side. I personally believe that the
integrated site will offer additional content that makes it more valuable than
my site alone.
So, the
obvious question is, if you want to continue to follow The Inoculated Investor,
how should you sign up? Well, there are a number of ways and we want to make it
very convenient for people because the goal is to transition as many readers as
possible to the Cove Street site.
First,
you can bookmark the site on your web browser. Click here for the homepage of the Cove
Street blog and here for my new homepage. If you click
either link you will be able to sign up for our mailing list in the box located
on the right-hand side of the page. In order to not inundate people, we make
sure to only send out emails to subscribers that highlight recent blog content
once a week. At that point you will be able to pick and choose what you want to
read but I hope that you will sample material from all of the members of the
Cove Street team.
Next,
for those of you who are more used to using programs such as Google Reader to
access blog sites’ RSS feeds, you can sign up for Cove Street’s RSS feed by
clicking this link
(try using Internet Explorer if Google Chrome or Firefox won’t access the link).
For those of you who are already subscribers to The Inoculated Investor’s RSS feed,
we will take the liberty of signing you up for Cove Street’s RSS feed as well.
I hope you do not feel that this is an intrusion of your privacy and I
apologize for any inconvenience. I am just passionate about not losing the
people who have followed me over the past few years. If you do not want to view
Cove Street content through your RSS reader, feel free to delete the
confirmation email you receive or simply email us at Questions@CoveStreetCapital.com.
Finally,
I want to assure you that the current site is not going anywhere. For anyone
who wants to access old postings, they will remain available. In fact, I will
continue to post links to the newest content—that will be exclusively available
on Cove Street’s site—on the front page of The Inoculated Investor site.
However, as of December 1st, 2011, I will post a permanent link to
my new home and cease posting on the Blogger site.
My goal
has always been the same: to post valuable content that both informs readers
and resonates with them. As such, the change in locations will not alter my
objectives. I sincerely you hope you will follow me in this new endeavor. If
you have any questions or comments, feel free to email me at inoculatedinvestor@gmail.com (this email will remain in use
as well).
Thank
you for all of your support. I leave with a link to my newest thought piece,
officially available on Cove Street’s blog site: In
a Zero Hedge World, Investors Must Stay Nimble.
Sincerely,
Ben Claremon
The Inoculated Investor
Analyst, Cove Street Capital
